Document is current
Any future updates will be listed below
-
Authors
Fang, Gang https://orcid.org/0000-0002-2462-9124
Wang, Wen https://orcid.org/0000-0002-5812-6744
Paunic, Vanja
Heydari, Hamed https://orcid.org/0000-0001-6708-9116
Costanzo, Michael https://orcid.org/0000-0002-7906-2604
Liu, Xiaoye
Liu, Xiaotong https://orcid.org/0000-0002-9164-5642
VanderSluis, Benjamin https://orcid.org/0000-0002-0299-5617
Oately, Benjamin
Steinbach, Michael https://orcid.org/0000-0002-7309-6395
Van Ness, Brian
Schadt, Eric E. https://orcid.org/0000-0002-7892-8808
Pankratz, Nathan D. https://orcid.org/0000-0001-5958-693X
Boone, Charles
Kumar, Vipin
Myers, Chad L. https://orcid.org/0000-0002-1026-5972
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01GM114472, R01HG005084, R01HG005853)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH097276, R01MH097276)
National Science Foundation (IIS0916439, 0953881)
- License Information
-
More Information
Article History
Received: 5 March 2019
Accepted: 20 August 2019
First Online: 19 September 2019
Competing interests
: C.M., M.C. and C.B. are cofounders of, and hold equity in, Bridge Genomics, which is negotiating a licensing agreement with the University of Minnesota for the method used in this paper. The method is described in a pending patent (PCT/US17/22308). The University of Minnesota also has equity and royalty interests in Bridge Genomics. These interests have been reviewed and managed by the University of Minnesota in accordance with its Conflict of Interest policies. The remaining authors declare no competing interests.
